Skip to content

In the BioHarmony Drug Report Database

Atosiban

Tractocile (atosiban) is a protein pharmaceutical. Atosiban was first approved as Tractocile on 2000-01-20. It has been approved in Europe to treat premature birth. It is known to target vasopressin V1b receptor, vasopressin V1a receptor, oxytocin receptor, and vasopressin V2 receptor.
Trade Name Tractocile
Common Name Atosiban
Indication premature birth
Drug Class Oxytocin antagonists
Atosiban
Get full access now